Alife Health Secures FDA Clearance for AI-Powered Embryo Assessment Tool
Alife Health has obtained FDA clearance for its artificial intelligence-based embryo assessment system. This regulatory approval allows the company to market its AI tool for use in assisted reproductive technology, where it is designed to help clinicians evaluate embryos during the IVF process.
The clearance represents a notable development in